Neuroprotection from Estrogen Receptor Agonists in Stroke
Author Information
Author(s): Connell Barry J., Saleh Tarek M.
Primary Institution: Department of Biomedical Science, Atlantic Veterinary College, University of Prince Edward Island
Hypothesis
Selective activation of estrogen receptor subtypes (ERα and ERβ) would be neuroprotective following ischemia and/or ischemia-reperfusion, as well as prevent the associated autonomic dysfunction.
Conclusion
The study found that ERα and ERβ agonists provide different neuroprotective effects against ischemic and reperfusion injuries.
Supporting Evidence
- ERα agonist PPT provided significant neuroprotection in permanent MCAO models.
- ERβ agonist DPN provided significant neuroprotection in ischemia-reperfusion models.
- Both agonists prevented the depression in baroreceptor reflex sensitivity following stroke.
Takeaway
This study shows that different types of estrogen can help protect the brain during a stroke, but they work in different ways depending on the type of injury.
Methodology
The study involved male Sprague-Dawley rats undergoing middle cerebral artery occlusion (MCAO) and treatment with selective estrogen receptor agonists.
Limitations
The study was conducted on animal models, which may not fully translate to human conditions.
Participant Demographics
Male Sprague-Dawley rats, 250–350 g.
Statistical Information
P-Value
p≤0.05
Statistical Significance
p≤0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website